<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63904">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02093637</url>
  </required_header>
  <id_info>
    <org_study_id>FDG20120024H</org_study_id>
    <nct_id>NCT02093637</nct_id>
  </id_info>
  <brief_title>Rapid Extremity Pain Relief by Battlefield Acupuncture After Orthopedic Surgery</brief_title>
  <official_title>Rapid Extremity Pain Relief by Battlefield Acupuncture After Orthopedic Surgery: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mike O'Callaghan Federal Hospital</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mike O'Callaghan Federal Hospital</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the addition of Battlefield Auricular
      Acupuncture (BFA) to standard therapy causes reduction in pain, medication use, time to
      ambulation without assistance, hours missed from work and increases quality of life after
      lower extremity surgery at two Air Force Medical Centers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will recruit 195 subjects into this research study, for an expected 150 completing the
      study. We estimate 45 subjects will either withdraw consent or become ineligible for the
      study.  Subjects will be â‰¥18 years or older and scheduled for lower extremity surgery.  To
      randomize subjects, we will employ a random number generator, which will minimize difference
      between study groups.  Additionally, we will collect data about patients' length of hospital
      stay, which will allow for statistical control of the variable, complexity of surgical
      procedure. The Research Assistants/Coordinators will be responsible for obtaining Informed
      Consent and HIPAA Authorization from subjects, collecting data, and de-identifying  data
      prior to review and analysis by the Investigators. The Investigators will be responsible for
      ongoing protocol monitoring, insertion of needles, verifying inclusion/exclusion criteria,
      and analyzing data.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain score</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Placebo acupuncture</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo acupuncture up to 5 acupuncture needles* in each ear (up to 10 needles total) at points identified by point-finder to have no electrical conductance) plus usual operative and post-operative care (narcotic and non-narcotic pain medication).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Battlefield Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Usual operative and post-operative care (narcotic and non-narcotic pain medication) plus Battlefield Acupuncture (up to 5 acupuncture needles* in each ear (up to 10 needles total), identified by a point-finder.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo acupuncture</intervention_name>
    <description>Placebo Comparator</description>
    <arm_group_label>Placebo acupuncture</arm_group_label>
    <other_name>ASP needles</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Battlefield Acupuncture</intervention_name>
    <description>Experimental</description>
    <arm_group_label>Battlefield Acupuncture</arm_group_label>
    <other_name>ASP needles</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female subjects (DoD beneficiaries), 18 years or older scheduled for lower
             extremity surgery below the hip (surgery may be performed by either orthopedics or
             podiatry or general surgery).

        Exclusion Criteria:

          -  Pregnant or breastfeeding

          -  Absence of ear

          -  Active cellulitis of ear

          -  Ear anatomy precluding identification of acupuncture landmarks

          -  Non-English speaking

          -  Use of Hearing Aids that preclude the insertion of ASP needles

          -  Inability to comply with study protocol
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Crawford, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MOFMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jill M Clark, MBA/HCM</last_name>
    <phone>(702) 653-3298</phone>
    <email>jill.clark.3.ctr@us.af.mil</email>
  </overall_contact>
  <location>
    <facility>
      <name>David Grant Medical Center</name>
      <address>
        <city>Travis AFB</city>
        <state>California</state>
        <zip>94535</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arthur Stout</last_name>
      <email>arthur.stout@us.af.mil</email>
    </contact>
    <investigator>
      <last_name>Katie Crowder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mike O'Callaghan Federal Medical Center</name>
      <address>
        <city>Nellis AFB</city>
        <state>Nevada</state>
        <zip>89191</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill M Clark, MBA/HCM</last_name>
      <phone>702-653-3298</phone>
      <email>jill.clark.3.ctr@us.af.mil</email>
    </contact>
    <investigator>
      <last_name>Paul Crawford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 19, 2014</lastchanged_date>
  <firstreceived_date>July 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
